Alimentiv is a GI focused global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and statistical services to the pharmaceutical and biotechnology industries. Alimentiv is headquartered in London, Ontario, with offices in San Diego, USA and Amsterdam, Netherlands and employees also operational in Asia-Pacific and Latin America. Alimentiv offers end-to-end services and trial management for full-service clinical trial studies (Phase I-IV) and help companies design and operationalize gastrointestinal trials and imaging solutions in an integrated, professional, evidence-based way that meets complex global operational needs and regulatory standards. The organization’s unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers.

Over the past 20 years, Alimentiv has become a recognized expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in IBD. Today, Alimentiv provides services in more than 50 countries worldwide, collaborates with leading universities and academic institutions across the globe, and partners with many leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients.

Alimentiv is committed to investment in medical research and development, focusing on identifying barriers to drug development and pursuing solutions that advance IBD research. The research findings are operationalized into an efficient clinical trial methodology for clients that aligns with emerging regulatory standards. In collaboration with leading experts, Alimentiv has pioneered the development, validation, and standardization of outcome measures and technology, shaping the evolving clinical trial landscape for multiple indications and providing meaningful long-term consequences for patients, their treatment, and society.

Role in METHYLOMIC project

Alimentiv is a partner in the Methylomic project more specifically the OMICROHN clinical performance study. Alimentiv will provide end to end project management.  These services will include project management, data management, risk-based monitoring, regulatory and statistical support as well as central image management for endoscopy, intestinal ultrasound and histology.

Website LinkedIn Twitter